<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Natl Compr Canc Netw</journal-id><journal-id journal-id-type="iso-abbrev">J Natl Compr Canc Netw</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Journal of the National Comprehensive Cancer Network : JNCCN</journal-title></journal-title-group><issn pub-type="ppub">1540-1405</issn><issn pub-type="epub">1540-1413</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11188046</article-id><article-id pub-id-type="pmcid-ver">PMC11188046.319</article-id><article-id pub-id-type="pmcaid">11188046</article-id><article-id pub-id-type="pmcaiid">11188046</article-id><article-id pub-id-type="manuscript-id">NIHMS2001431</article-id><article-id pub-id-type="pmid">38394782</article-id><article-id pub-id-type="doi">10.6004/jnccn.2023.7076</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2001431</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2001431</article-id><article-version article-version-type="pmc-version">319</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Association Between Alcohol Use Disorder and Hospital Readmission Rates and Outcomes in Cancer Survivors: A Population Cohort Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Lai</surname><given-names initials="JH">Jyun-Heng</given-names></name><degrees>BPharm, MS</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Han</surname><given-names initials="S">Sola</given-names></name><degrees>PharmD, PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Park</surname><given-names initials="C">Chanhyun</given-names></name><degrees>PhD, MPharm, MEd</degrees><xref rid="A1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Avance&#241;a</surname><given-names initials="ALV">Anton L.V.</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib></contrib-group><aff id="A1"><label>1</label>Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, Austin, Texas,</aff><aff id="A2"><label>2</label>Department of Internal Medicine, Dell Medical School, The University of Texas at Austin, Austin, Texas.</aff><author-notes><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">These authors contributed equally to this study.</p></fn><fn fn-type="con" id="FN2"><p id="P2"><bold>Author contributions:</bold>
<italic toggle="yes">Study concept and design:</italic> Park, Avance&#241;a. <italic toggle="yes">Data acquisition, analysis, or interpretation:</italic> All authors. <italic toggle="yes">Statistical analysis:</italic> Lai, Han, Avance&#241;a. <italic toggle="yes">Administrative, technical, or material support:</italic> Park, Avance&#241;a. <italic toggle="yes">Supervision:</italic> Park, Avance&#241;a. <italic toggle="yes">Manuscript preparation:</italic> Lai, Avance&#241;a. <italic toggle="yes">Critical revision for important intellectual content:</italic> All authors.</p></fn><corresp id="CR1"><bold>Correspondence:</bold> Anton L.V. Avance&#241;a, PhD, Health Outcomes Division, College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, PHR 2.112, Austin, TX 78712. <email>antonlv@utexas.edu</email></corresp></author-notes><pub-date pub-type="ppub"><month>2</month><year>2024</year></pub-date><volume>22</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">465108</issue-id><elocation-id>e237076</elocation-id><pub-history><event event-type="nihms-submitted"><date><day>13</day><month>06</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>20</day><month>06</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>20</day><month>06</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-06-22 07:25:13.933"><day>22</day><month>06</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2001431.pdf"/><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P3">Alcohol use disorder (AUD) is the most common substance use disorder and is characterized by heavy alcohol use and the inability to control drinking. This study sought to compare the rate, timing, length, and total costs of hospital readmissions among cancer survivors with and without AUD.</p></sec><sec id="S2"><title>Methods:</title><p id="P4">We used the Nationwide Readmissions Database in 2017 and 2018 in this cohort study. Cancer survivors with an AUD diagnosis during their index hospitalization were included in the exposure group. Propensity score matching was used to identify cancer survivors without AUD for the control group. The primary outcome was all-cause readmission, and secondary outcomes included days to, length of, and total cost of readmission. Outcomes were measured after 90 and 180 days of follow-up. Logistic regression was used to measure the likelihood of readmission, and negative binomial regression and gamma regression were used for the other outcomes.</p></sec><sec id="S3"><title>Results:</title><p id="P5">Of 485,962 cancer survivors, 13,953 (2.9%) had co-occurring AUD. Cancer survivors with AUD had slightly higher odds of 90-day (odds ratio, 1.14; 95% CI, 1.06&#8211;1.22) and 180-day (odds ratio, 1.11; 95% CI, 1.05&#8211;1.18) readmission compared with those without AUD. Cancer survivors with AUD who were readmitted after 90 days also had higher readmission costs ($3,785 vs $3,376; <italic toggle="yes">P</italic>=.03). No differences in time to and length of readmission were observed between groups. The odds of readmission were higher among cancer survivors with AUD irrespective of age and type of cancer. Male, but not female, cancer survivors with AUD were more likely than those without AUD to be readmitted in both follow-up periods.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P6">This population-based cohort study of cancer survivors in the United States found that AUD is associated with higher 90- and 180-day readmission rates and higher related health care costs after 90 days of follow-up. Hospitalized cancer survivors with AUD may benefit from addiction treatment and discharge planning that addresses their co-occurring AUD.</p></sec></abstract><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>